DZNE neuroepidemiologist honored for her research on dementia. The election recognizes her outstanding academic work and international scientific leadership.
Bonn/Amsterdam, September 30th, 2015 –…
Researchers in Göttingen have identified a cancer drug as a prototype drug that may be used to treat Alzheimer’s disease. This substance, known as “Vorinostat”, was found to alleviate learning and…
A team led by Christian Haass has identified a novel peptide that plays a role in Alzheimer’s disease: The previously overlooked eta-amyloid interferes with neuronal function and may antogonize…
The polar bear suffered from an autoimmune disease of the brain. This non-infectious illness is called “anti-NMDA receptor encephalitis”, with symptoms in human patients similar to those displayed by…
British neuroscientist John Hardy will be awarded this year’s “Hartwig Piepenbrock-DZNE Prize” which is endowed with 60,000 Euro. Piepenbrock and the DZNE herewith honor his seminal contributions to…
Professor Christian Haass, site speaker at the DZNE in Munich, yesterday has been honored by MetLife Foundation in the USA at the Alzheimer’s Association International Conference in Washington DC.…
The number of people in Germany who require nursing care has been rising steadily for years. Demographic developments indicate that this trend will continue. A parallel increase in the number of…
Treating people with type 2 diabetes, also known as "age-related diabetes" with antidiabetics reduces their risk for Alzheimer’s and other types of dementia. The risk is most significantly reduced by…
Researchers in Bonn have identified neural circuits in the brains of mice that are pivotal for movement and navigation in space. These nerve cells that are presumed to exist in a similar form in…
An international team of researchers at DZNE and Tokyo Tech have revealed in a collaborative study - published today in Neuron, that neurons in the eye change on the molecular level when they are…
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
